GLP-1 contributes to increases in PGC-1 expression by downregulating miR-23a to reduce apoptosis
Expression of neither Sod1 , Sod2 and Sod3, nor Cat, was significantly affected by UQCR-C1 knockdown (Additional File 9: Fig
Current therapies like semaglutide primarily target GLP-1 receptors
In the 2021 Nature Communications study, Reynolds, Lai, and Lee demonstrated that MOTS-c treatment significantly enhanced physical performance in young, middle-aged, and old mice
Japans advanced convenience retail ecosystem and functional food culture are increasing demand for compact protein supplements, hydration products, and digestive-support formulations compatible with reduced-calorie dietary routines
Protocolo de Investigacin Teraputica Dosis: 0,3 0,5 mg (= 610 clics) Duracin: 12 semanas Frecuencia: 2 3 al da, con 4 6 horas de separacin Intervalo de ciclo: 4 6 semanas de descanso antes de repetir Objetivo / Descripcin: Elevacin de mayor amplitud de GH e IGF-1 en modelos regenerativos y metablicos